Protective Effects of Endothelin Receptor Antagonists in Dogs with Aortic Cross-Clamping
Authors:
- Sébastien RouxSRSébastien Roux
- Changbin QiuCQChangbin Qiu
- Urs SprecherUSUrs Sprecher
- Rolf OsterwalderRORolf Osterwalder
- Jean-Paul ClozelJCJean-Paul Clozel
- 1 August 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 34 (2) , 199-205
Abstract
Endothelin (ET) may play an important role in the pathogenesis of vasoconstriction and acute renal failure after aortic cross-clamping (ACC). However, the relative contribution of the ETA and ETB receptors to the physiopathology of ischemic acute renal failure is poorly understood. This study was carried out to evaluate the potential protective effect of a selective ETA antagonist versus combined ETA/ETB antagonist on altered systemic, pulmonary, and renal hemodynamics induced by cross-clamping the suprarenal aorta for 1 h, followed by 2-h reperfusion. Studies were performed in three groups of anesthetized mongrel dogs. After baseline measurements, treatment (3 mg/kg i.v. bolus + 3 mg/kg/h infusion) with either a selective ETA antagonist, Ro 61-1790 (n = 5), or a combined ETA/ETB antagonist, bosentan (n = 5) or vehicle (n = 8) was initiated 5 min before ACC. There were marked increases in total peripheral (TPR), pulmonary (PVR), and renal (RVR) vascular resistances, and significant decreases in cardiac output (CO) and glomerular filtration rate (GFR) and tubular sodium reabsorption after ACC in the vehicle group. Both Ro 61-1790 and bosentan prevented the marked increases in TPR, PRV, and RVR, and attenuated the declines in CO, GFR, and tubular sodium reabsorption. We concluded that the profound systemic, pulmonary, and renal vasoconstriction, as well as the impairments in glomerular and tubular functions associated with ACC, is mostly ET mediated and that the ETA receptor activation makes a major contribution to the ET-mediated impairments of hemodynamics and renal function after ACC.Keywords
This publication has 22 references indexed in Scilit:
- Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive ratsKidney International, 1994
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994
- Radioimmunological Determination of Endothelin Peptides in Human Plasma: A Methodological ApproachEndothelium, 1994
- Effect of different endothelin receptor antagonists and of the novel non‐peptide antagonist Ro 46‐2005 on endothelin levels in rat plasmaFEBS Letters, 1993
- Biological role for the endothelin-A receptor in aortic cross-clamping.Hypertension, 1993
- Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptorNature, 1990
- Cloning and expression of a cDNA encoding an endothelin receptorNature, 1990
- Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways.Journal of Clinical Investigation, 1989
- Integrated cardiac, renal, and endocrine actions of endothelin.Journal of Clinical Investigation, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988